Medscape November 10, 2023

(Reuters) – The U.S. Food and Drug Administration (FDA) on Thursday cleared an over-the-counter at-home COVID-19 antigen test made by Acon Laboratories.

Acon’s test is the second coronavirus test to get marketing authorization using the agency’s traditional premarket review pathway and the first indicated for use in children under 18, the health regulator said.

The FDA had...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article